Menu
Annual · values202520242023202220212020201920182017201620152014
Operating Cash Flow7.82 B USD8.67 B USD8.41 B USD9.15 B USD9.31 B USD8.29 B USD4.97 B USD4.54 B USD4.00 B USD3.16 B USD2.82 B USD2.62 B USD
Depreciation & Amortization1.05 B USD1.16 B USD1.07 B USD986.00 M USD831.00 M USD658.00 M USD564.00 M USD2.27 B USD2.03 B USD1.76 B USD1.69 B USD1.68 B USD
Stock-Based Compensation310.00 M USD301.00 M USD278.00 M USD307.00 M USD230.00 M USD196.00 M USD181.00 M USD181.00 M USD159.00 M USD133.50 M USD125.00 M USD117.10 M USD
Capital Expenditures1.52 B USD1.40 B USD1.48 B USD2.24 B USD2.52 B USD1.47 B USD926.00 M USD758.00 M USD508.00 M USD444.40 M USD422.90 M USD427.60 M USD
Cash Flow from Investing-4.05 B USD-5.84 B USD-5.14 B USD-2.16 B USD-21.93 B USD-1.51 B USD-1.49 B USD-1.25 B USD-7.73 B USD-5.52 B USD-1.09 B USD-11.78 B USD
Cash Flow from Financing1.80 B USD-6.79 B USD-3.62 B USD-2.81 B USD6.58 B USD959.00 M USD-3.12 B USD-2.24 B USD3.85 B USD2.76 B USD-2.62 B USD4.80 B USD
Dividends Paid636.00 M USD583.00 M USD523.00 M USD455.00 M USD395.00 M USD337.00 M USD297.00 M USD266.00 M USD237.00 M USD238.40 M USD240.60 M USD234.80 M USD
Stock Buybacks3.00 B USD4.00 B USD3.00 B USD3.00 B USD2.00 B USD1.50 B USD1.50 B USD500.00 M USD750.00 M USD1.25 B USD500.00 M USD0 USD
Free Cash Flow6.29 B USD7.27 B USD6.93 B USD6.91 B USD6.79 B USD6.82 B USD4.05 B USD3.79 B USD3.50 B USD2.71 B USD2.39 B USD2.19 B USD

Thermo Fisher Scientific Inc. is a leading provider of scientific instruments, laboratory equipment, diagnostics consumables, and life science reagents. The company operates through four main segments: analytical technologies, which focuses on advanced instrumentation for research and analysis; specialty diagnostic products for clinical and healthcare applications; life science solutions offering reagents and tools for biological research; and lab products and services, including contract research organization services to support scientific workflows. These offerings enable advancements in healthcare, pharmaceuticals, biotechnology, and academic research by delivering high-quality tools for discovery, development, and production processes. Thermo Fisher Scientific Inc. serves a global customer base across research institutions, pharmaceutical companies, diagnostics providers, and industrial sectors, facilitating innovation in drug development, genomics, proteomics, and clinical diagnostics. Founded in 2006 and headquartered in Waltham, Massachusetts, Thermo Fisher Scientific Inc. plays a pivotal role in enabling scientific breakthroughs and operational efficiency in life sciences and healthcare markets.